210 related articles for article (PubMed ID: 36476039)
1. Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus.
Rivera-Gonzalez O; Case CT; Wilson NA; Speed JS; Taylor EB
Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E73-E84. PubMed ID: 36476039
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese mice.
Rivera-Gonzalez O; Wilson NA; Coats LE; Taylor EB; Speed JS
Clin Sci (Lond); 2021 Jul; 135(14):1773-1789. PubMed ID: 34278410
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and obesity in a mouse model of systemic lupus erythematosus.
Ryan MJ; McLemore GR; Hendrix ST
Hypertension; 2006 Nov; 48(5):988-93. PubMed ID: 16982954
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure and albuminuria in a female mouse model of systemic lupus erythematosus: impact of long-term high salt consumption.
Dent EL; Broome HJ; Sasser JM; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2020 Oct; 319(4):R448-R454. PubMed ID: 32813539
[TBL] [Abstract][Full Text] [Related]
6. Metabolic responses with endothelin antagonism in a model of insulin resistance.
Berthiaume N; Wessale JL; Opgenorth TJ; Zinker BA
Metabolism; 2005 Jun; 54(6):735-40. PubMed ID: 15931607
[TBL] [Abstract][Full Text] [Related]
7. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
Berthiaume N; Carlson CJ; Rondinone CM; Zinker BA
Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus.
Gabriel CL; Smith PB; Mendez-Fernandez YV; Wilhelm AJ; Ye AM; Major AS
Am J Physiol Endocrinol Metab; 2012 Dec; 303(11):E1313-24. PubMed ID: 23032686
[TBL] [Abstract][Full Text] [Related]
9. Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase.
Briançon-Marjollet A; Monneret D; Henri M; Hazane-Puch F; Pepin JL; Faure P; Godin-Ribuot D
J Physiol; 2016 Mar; 594(6):1727-40. PubMed ID: 26663321
[TBL] [Abstract][Full Text] [Related]
10. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
[TBL] [Abstract][Full Text] [Related]
11. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus.
Venegas-Pont M; Sartori-Valinotti JC; Maric C; Racusen LC; Glover PH; McLemore GR; Jones AV; Reckelhoff JF; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1282-9. PubMed ID: 19193937
[TBL] [Abstract][Full Text] [Related]
13. Distortion of K
Angus JA; Hughes RJA; Wright CE
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226623
[TBL] [Abstract][Full Text] [Related]
14. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
Vernerová Z; Kujal P; Kramer HJ; Bäcker A; Cervenka L; Vaneckova I
Physiol Res; 2009; 58 Suppl 2():S69-S78. PubMed ID: 20131938
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor blockade blunts the pressor response to acute stress in men and women with obesity.
Derella CC; Blanks AM; Wang X; Tucker MA; Horsager C; Jeong JH; Rodriguez-Miguelez P; Looney J; Thomas J; Pollock DM; Harris RA
J Appl Physiol (1985); 2022 Jan; 132(1):73-83. PubMed ID: 34762528
[TBL] [Abstract][Full Text] [Related]
16. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.
Venegas-Pont M; Manigrasso MB; Grifoni SC; LaMarca BB; Maric C; Racusen LC; Glover PH; Jones AV; Drummond HA; Ryan MJ
Hypertension; 2010 Oct; 56(4):643-9. PubMed ID: 20696988
[TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus.
Dent EL; Taylor EB; Turbeville HR; Ryan MJ
Physiol Rep; 2020 Jul; 8(13):e14501. PubMed ID: 32652896
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
[TBL] [Abstract][Full Text] [Related]
20. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
